Insulin resistance of glucose uptake in skeletal muscle cannot be ameliorated by enhancing endothelium-dependent blood flow in obesity.
about
The pharmacokinetics of the interstitial space in humansDecreased insulin-stimulated ATP synthesis and phosphate transport in muscle of insulin-resistant offspring of type 2 diabetic parentsMuscle perfusion: its measurement and role in metabolic regulationRegulation of obesity and insulin resistance by nitric oxideAdiponectin and insulin cross talk: the microvascular connection.Insulin regulates its own delivery to skeletal muscle by feed-forward actions on the vasculature.The vascular actions of insulin control its delivery to muscle and regulate the rate-limiting step in skeletal muscle insulin actionSkeletal muscle capillary responses to insulin are abnormal in late-stage diabetes and are restored by angiotensin-converting enzyme inhibition.Endogenous nitric oxide contributes to bradykinin-stimulated glucose uptake but attenuates vascular tissue-type plasminogen activator release.Severe impairment of endothelial function with the HIV-1 protease inhibitor indinavir is not mediated by insulin resistance in healthy subjects.PET as a cardiovascular and metabolic research tool.Insulin action in vascular endothelium: potential mechanisms linking insulin resistance with hypertension.Metabolomic analyses for atherosclerosis, diabetes, and obesity.Increasing exercise intensity reduces heterogeneity of glucose uptake in human skeletal musclesAntiobesogenic role of endothelial nitric oxide synthase.Insulin resistance and endothelial cell dysfunction: studies in mammalian models.Blocking the renin-angiotensin-aldosterone system to prevent diabetes mellitus.The sweeter side of ACE2: physiological evidence for a role in diabetes.Dynamic PET imaging reveals heterogeneity of skeletal muscle insulin resistance.Contribution of insulin resistance to vascular dysfunction.The role of IGF-1 resistance in obesity and type 2 diabetes-mellitus-related insulin resistance and vascular disease.The IGF-1 receptor and regulation of nitric oxide bioavailability and insulin signalling in the endothelium.Skeletal Muscle Vascular Function: A Counterbalance of Insulin Action.Insulin resistance: an additional risk factor in the pathogenesis of cardiovascular disease in type 2 diabetes.Extracellular superoxide dismutase is a growth regulatory mediator of tissue injury recovery.2-[(18)F]fluoro-2-deoxy-D-glucose combined with microdialysis can be used for the comparison of tissue glucose metabolism in obese and lean rats.Obesity affects myocardial vasoreactivity and coronary flow response to insulin.Insulin- and exercise-stimulated skeletal muscle blood flow and glucose uptake in obese men.Stimulatory effect of leptin on nitric oxide production is impaired in dietary-induced obesity.Vascular endothelial dysfunction tested by blunted response to endothelium-dependent vasodilation by salbutamol and its related factors in uncomplicated pre-menopausal obese women.Insulin resistance and endothelial dysfunction in smokers: effects of vitamin C.Sodium nitroprusside increases human skeletal muscle blood flow, but does not change flow distribution or glucose uptake
P2860
Q24798119-25E45B33-1882-4431-8FCF-8804DDB6C14AQ24812499-25119AFB-D8CC-4198-AE37-895231F4BAB0Q27026527-45741693-376D-40D8-9500-52D9722C44C2Q30363035-9F311141-5434-4C11-BBA4-24367E9E17CBQ30370241-AA5AB8CB-F34B-4481-AC37-AA859CEF4701Q30425679-AAAE890F-BA76-43FB-9656-6392C093252DQ30436236-5BDE8683-A409-465C-A2F8-288452A24992Q30444650-6E60489B-7E81-44EF-80FF-59324CB5BEDCQ33574874-15F68853-91A0-4D29-A1E1-9B821B1A4FB4Q33816114-4E51640D-C8EB-498C-96C7-6B85134C8611Q33841677-7C326179-28BE-4FCC-8A90-F1868C4855BAQ34166377-997E2377-4127-4F15-8CCB-D4B4B6251F81Q34256164-289F640D-C385-4028-9985-57F7BA3EF95AQ34533282-FBD6348A-1213-4EB0-9972-115FC9C9B89DQ35540257-A6AE6EEE-1FFB-4C96-A656-31204F54E43EQ36969764-D0DF5F96-DAA2-40D9-A953-B0A57866AAABQ37132930-FE291432-37D7-4B22-937A-4B6A59BC4024Q37178255-DB6ACE88-5653-4C8C-B6D1-1827B85509EAQ37428947-4FE2CAB0-44C0-40BF-9098-985AEFC0F161Q37580907-8E67D887-4957-4EE9-A607-D52B7D64DE5AQ37807986-4D091CA3-80B0-4094-8608-634596C03E29Q38075845-23678557-29AD-42D4-85F2-717306D8FA77Q38436848-EB90799A-841E-4DA9-B7E4-7165D5007714Q38626570-09017F0B-9394-4C74-B25C-DB3E63033FD3Q39504593-F510B9BE-34F1-47A8-91B4-75BC504C69C3Q43902807-5BBE17EC-EC63-4F0B-A810-C25B2CFE5E81Q44053871-D3C281ED-59BA-48FA-B9BC-65BF9EB83CB4Q44312400-BDF5B0E2-981C-41DC-8345-3360DD4D4C1EQ44705326-A4DC699E-D8A8-4A8A-9217-89D0210F91F5Q45166960-1754427F-E6E1-4ACC-A586-FDB9A0DB9F49Q54036434-65B9B386-893E-418B-B938-43E639F53C3FQ57623280-BA87A85C-5B43-4A25-86E7-5A69A97482E7
P2860
Insulin resistance of glucose uptake in skeletal muscle cannot be ameliorated by enhancing endothelium-dependent blood flow in obesity.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
1998年论文
@zh
1998年论文
@zh-cn
name
Insulin resistance of glucose ...... pendent blood flow in obesity.
@en
Insulin resistance of glucose ...... pendent blood flow in obesity.
@nl
type
label
Insulin resistance of glucose ...... pendent blood flow in obesity.
@en
Insulin resistance of glucose ...... pendent blood flow in obesity.
@nl
prefLabel
Insulin resistance of glucose ...... pendent blood flow in obesity.
@en
Insulin resistance of glucose ...... pendent blood flow in obesity.
@nl
P2093
P2860
P921
P356
P1476
Insulin resistance of glucose ...... pendent blood flow in obesity.
@en
P2093
Haaparanta M
Raitakari M
Tolvanen T
P2860
P304
P356
10.1172/JCI1065
P407
P577
1998-03-01T00:00:00Z